SKI Market

Indian Indices

Nifty

22,419.95 -150.40
(-0.67%)

Sensex

73,730.16 -609.28
( -0.82%)

Bank Nifty

48,201.05 -293.90
( -0.61%)

Nifty IT

33,666.20 111.80
( 0.33%)

Global Indices

Nasdaq

15,927.90 316.14
(2.03%)

Dow Jones

38,239.66 153.86
(0.40%)

Hang Seng

17,651.15 366.61
(2.12%)

Nikkei 225

37,934.76 306.28
(0.81%)

Forex

USD-INR

83.32 0.01
(0.01%)

EUR-INR

89.30 0.19
(0.22%)

GBP-INR

104.10 0.39
(0.38%)

JPY-INR

0.54 0.00
(-0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Kimia Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530313

INE285U01025

0.0815159

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

244.13

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	128.52	124.90	132.71	106.29	93.92	76.46
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	128.52	124.90	132.71	106.29	93.92	76.46
Other Income	1.21	0.93	2.46	0.96	1.33	0.86
Stock Adjustments	10.36	3.77	6.27	-1.15	1.14	1.26
Total Income	140.09	129.60	141.44	106.10	96.39	78.58
EXPENDITURE :
Raw Materials	106.39	96.03	103.13	79.09	72.22	60.58
Power & Fuel Cost	7.29	6.54	4.54	3.21	2.54	1.85
Employee Cost	16.40	15.08	14.09	10.80	8.82	7.80
Other Manufacturing Expenses	2.93	2.40	2.64	1.74	1.08	1.01
Selling & Administrative Expenses	7.04	6.16	4.88	3.76	2.33	2.32
Miscellaneous Expenses	4.85	1.82	1.33	2.08	2.50	1.92
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.23
Total Expenditure	144.90	128.04	130.61	100.68	89.48	75.25
Operating Profit	-4.81	1.56	10.84	5.42	6.90	3.33
Interest	4.25	3.64	3.39	2.53	2.00	0.58
Gross Profit	-9.06	-2.08	7.45	2.89	4.90	2.75
Depreciation	3.33	2.94	1.91	1.66	1.10	1.14
Profit Before Tax	-12.39	-5.02	5.54	1.23	3.80	1.61
Tax	0.00	0.00	0.00	-0.16	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-3.04	-1.32	0.43	0.00	-0.05	-0.06
Reported Net Profit	-9.35	-3.70	5.10	1.38	3.86	1.67
Extraordinary Items	-1.05	0.08	0.07	-0.01	0.02	0.01
Adjusted Net Profit	-8.30	-3.78	5.03	1.39	3.84	1.66
Adjustment below Net Profit	-0.07	0.16	-0.04	0.00	0.00	0.00
P & L Balance brought forward	4.07	7.62	2.56	1.23	-2.62	-4.29
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-5.35	4.07	7.62	2.61	1.23	-2.62
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-1.98	-0.78	1.08	0.30	2.64	1.14
Earnings Per Share(Adj)-Unit Curr	-1.98	-0.78	1.08	0.30	2.64	1.14
Book Value-Unit Curr	1.15	3.15	3.90	2.86	2.39	-0.23
Book Value(Adj)-Unit Curr	1.15	3.15	3.90	2.86	2.39	-0.23

22,419.95 -150.40 (-0.67%)

73,730.16 -609.28 ( -0.82%)

48,201.05 -293.90 ( -0.61%)

33,666.20 111.80 ( 0.33%)

15,927.90 316.14 (2.03%)

38,239.66 153.86 (0.40%)

17,651.15 366.61 (2.12%)

37,934.76 306.28 (0.81%)

83.32 0.01 (0.01%)

89.30 0.19 (0.22%)

104.10 0.39 (0.38%)

0.54 0.00 (-0.34%)